Request Your Free White Paper Now:

"Most Favored Nation and the Future of Drug Pricing and Access"

Download this white paper to learn more.

The U.S. Most Favored Nation (MFN) policy is moving from debate to enforcement with 60-day deadlines, affecting launch pricing, contracts, and global sequencing. Explore key policy insights and impacts in Herspiegel’s Policy Brief.